4.1. Analysis.
Comparison 4: Comparison 4: annualised relapse rate, Outcome 1: Siponimod 2 mg versus placebo, annualised relapse rate
Comparison 4: Comparison 4: annualised relapse rate, Outcome 1: Siponimod 2 mg versus placebo, annualised relapse rate